The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Follitropin Market Research Report 2024
Synopsis
Follitropin is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids.
The global Follitropin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Follitropin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Follitropin.
Report Scope
The Follitropin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Follitropin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Follitropin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gedeon Richter
Organon
Ferring
Emd Serono (Merck)
Johnson & Johnson
Solvay
Controlled Therapeutics
Vetter Pharma-Fertigung GmbH&Co. KG
MSD
IBSA
Livzon
Techwell
GenSci
Teva
Segment by Type
Urine-Derived Follicle Stimulating Hormone
Follitropin-α
Follitropin-β
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Follitropin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Follitropin is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids.
The global Follitropin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Follitropin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Follitropin.
Report Scope
The Follitropin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Follitropin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Follitropin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gedeon Richter
Organon
Ferring
Emd Serono (Merck)
Johnson & Johnson
Solvay
Controlled Therapeutics
Vetter Pharma-Fertigung GmbH&Co. KG
MSD
IBSA
Livzon
Techwell
GenSci
Teva
Segment by Type
Urine-Derived Follicle Stimulating Hormone
Follitropin-α
Follitropin-β
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Follitropin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Follitropin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Urine-Derived Follicle Stimulating Hormone
1.2.3 Follitropin-α
1.2.4 Follitropin-β
1.3 Market by Application
1.3.1 Global Follitropin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Follitropin Market Perspective (2019-2030)
2.2 Follitropin Growth Trends by Region
2.2.1 Global Follitropin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Follitropin Historic Market Size by Region (2019-2024)
2.2.3 Follitropin Forecasted Market Size by Region (2025-2030)
2.3 Follitropin Market Dynamics
2.3.1 Follitropin Industry Trends
2.3.2 Follitropin Market Drivers
2.3.3 Follitropin Market Challenges
2.3.4 Follitropin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Follitropin Players by Revenue
3.1.1 Global Top Follitropin Players by Revenue (2019-2024)
3.1.2 Global Follitropin Revenue Market Share by Players (2019-2024)
3.2 Global Follitropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Follitropin Revenue
3.4 Global Follitropin Market Concentration Ratio
3.4.1 Global Follitropin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Follitropin Revenue in 2023
3.5 Follitropin Key Players Head office and Area Served
3.6 Key Players Follitropin Product Solution and Service
3.7 Date of Enter into Follitropin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Follitropin Breakdown Data by Type
4.1 Global Follitropin Historic Market Size by Type (2019-2024)
4.2 Global Follitropin Forecasted Market Size by Type (2025-2030)
5 Follitropin Breakdown Data by Application
5.1 Global Follitropin Historic Market Size by Application (2019-2024)
5.2 Global Follitropin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Follitropin Market Size (2019-2030)
6.2 North America Follitropin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Follitropin Market Size by Country (2019-2024)
6.4 North America Follitropin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Follitropin Market Size (2019-2030)
7.2 Europe Follitropin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Follitropin Market Size by Country (2019-2024)
7.4 Europe Follitropin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Follitropin Market Size (2019-2030)
8.2 Asia-Pacific Follitropin Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Follitropin Market Size by Region (2019-2024)
8.4 Asia-Pacific Follitropin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Follitropin Market Size (2019-2030)
9.2 Latin America Follitropin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Follitropin Market Size by Country (2019-2024)
9.4 Latin America Follitropin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Follitropin Market Size (2019-2030)
10.2 Middle East & Africa Follitropin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Follitropin Market Size by Country (2019-2024)
10.4 Middle East & Africa Follitropin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gedeon Richter
11.1.1 Gedeon Richter Company Detail
11.1.2 Gedeon Richter Business Overview
11.1.3 Gedeon Richter Follitropin Introduction
11.1.4 Gedeon Richter Revenue in Follitropin Business (2019-2024)
11.1.5 Gedeon Richter Recent Development
11.2 Organon
11.2.1 Organon Company Detail
11.2.2 Organon Business Overview
11.2.3 Organon Follitropin Introduction
11.2.4 Organon Revenue in Follitropin Business (2019-2024)
11.2.5 Organon Recent Development
11.3 Ferring
11.3.1 Ferring Company Detail
11.3.2 Ferring Business Overview
11.3.3 Ferring Follitropin Introduction
11.3.4 Ferring Revenue in Follitropin Business (2019-2024)
11.3.5 Ferring Recent Development
11.4 Emd Serono (Merck)
11.4.1 Emd Serono (Merck) Company Detail
11.4.2 Emd Serono (Merck) Business Overview
11.4.3 Emd Serono (Merck) Follitropin Introduction
11.4.4 Emd Serono (Merck) Revenue in Follitropin Business (2019-2024)
11.4.5 Emd Serono (Merck) Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Follitropin Introduction
11.5.4 Johnson & Johnson Revenue in Follitropin Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Solvay
11.6.1 Solvay Company Detail
11.6.2 Solvay Business Overview
11.6.3 Solvay Follitropin Introduction
11.6.4 Solvay Revenue in Follitropin Business (2019-2024)
11.6.5 Solvay Recent Development
11.7 Controlled Therapeutics
11.7.1 Controlled Therapeutics Company Detail
11.7.2 Controlled Therapeutics Business Overview
11.7.3 Controlled Therapeutics Follitropin Introduction
11.7.4 Controlled Therapeutics Revenue in Follitropin Business (2019-2024)
11.7.5 Controlled Therapeutics Recent Development
11.8 Vetter Pharma-Fertigung GmbH&Co. KG
11.8.1 Vetter Pharma-Fertigung GmbH&Co. KG Company Detail
11.8.2 Vetter Pharma-Fertigung GmbH&Co. KG Business Overview
11.8.3 Vetter Pharma-Fertigung GmbH&Co. KG Follitropin Introduction
11.8.4 Vetter Pharma-Fertigung GmbH&Co. KG Revenue in Follitropin Business (2019-2024)
11.8.5 Vetter Pharma-Fertigung GmbH&Co. KG Recent Development
11.9 MSD
11.9.1 MSD Company Detail
11.9.2 MSD Business Overview
11.9.3 MSD Follitropin Introduction
11.9.4 MSD Revenue in Follitropin Business (2019-2024)
11.9.5 MSD Recent Development
11.10 IBSA
11.10.1 IBSA Company Detail
11.10.2 IBSA Business Overview
11.10.3 IBSA Follitropin Introduction
11.10.4 IBSA Revenue in Follitropin Business (2019-2024)
11.10.5 IBSA Recent Development
11.11 Livzon
11.11.1 Livzon Company Detail
11.11.2 Livzon Business Overview
11.11.3 Livzon Follitropin Introduction
11.11.4 Livzon Revenue in Follitropin Business (2019-2024)
11.11.5 Livzon Recent Development
11.12 Techwell
11.12.1 Techwell Company Detail
11.12.2 Techwell Business Overview
11.12.3 Techwell Follitropin Introduction
11.12.4 Techwell Revenue in Follitropin Business (2019-2024)
11.12.5 Techwell Recent Development
11.13 GenSci
11.13.1 GenSci Company Detail
11.13.2 GenSci Business Overview
11.13.3 GenSci Follitropin Introduction
11.13.4 GenSci Revenue in Follitropin Business (2019-2024)
11.13.5 GenSci Recent Development
11.14 Teva
11.14.1 Teva Company Detail
11.14.2 Teva Business Overview
11.14.3 Teva Follitropin Introduction
11.14.4 Teva Revenue in Follitropin Business (2019-2024)
11.14.5 Teva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Follitropin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Urine-Derived Follicle Stimulating Hormone
Table 3. Key Players of Follitropin-α
Table 4. Key Players of Follitropin-β
Table 5. Global Follitropin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Follitropin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Follitropin Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Follitropin Market Share by Region (2019-2024)
Table 9. Global Follitropin Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Follitropin Market Share by Region (2025-2030)
Table 11. Follitropin Market Trends
Table 12. Follitropin Market Drivers
Table 13. Follitropin Market Challenges
Table 14. Follitropin Market Restraints
Table 15. Global Follitropin Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Follitropin Market Share by Players (2019-2024)
Table 17. Global Top Follitropin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follitropin as of 2023)
Table 18. Ranking of Global Top Follitropin Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Follitropin Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Follitropin Product Solution and Service
Table 22. Date of Enter into Follitropin Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Follitropin Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Follitropin Revenue Market Share by Type (2019-2024)
Table 26. Global Follitropin Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Follitropin Revenue Market Share by Type (2025-2030)
Table 28. Global Follitropin Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Follitropin Revenue Market Share by Application (2019-2024)
Table 30. Global Follitropin Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Follitropin Revenue Market Share by Application (2025-2030)
Table 32. North America Follitropin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Follitropin Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Follitropin Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Follitropin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Follitropin Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Follitropin Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Follitropin Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Follitropin Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Follitropin Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Follitropin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Follitropin Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Follitropin Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Follitropin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Follitropin Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Follitropin Market Size by Country (2025-2030) & (US$ Million)
Table 47. Gedeon Richter Company Detail
Table 48. Gedeon Richter Business Overview
Table 49. Gedeon Richter Follitropin Product
Table 50. Gedeon Richter Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 51. Gedeon Richter Recent Development
Table 52. Organon Company Detail
Table 53. Organon Business Overview
Table 54. Organon Follitropin Product
Table 55. Organon Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 56. Organon Recent Development
Table 57. Ferring Company Detail
Table 58. Ferring Business Overview
Table 59. Ferring Follitropin Product
Table 60. Ferring Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 61. Ferring Recent Development
Table 62. Emd Serono (Merck) Company Detail
Table 63. Emd Serono (Merck) Business Overview
Table 64. Emd Serono (Merck) Follitropin Product
Table 65. Emd Serono (Merck) Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 66. Emd Serono (Merck) Recent Development
Table 67. Johnson & Johnson Company Detail
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Follitropin Product
Table 70. Johnson & Johnson Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 71. Johnson & Johnson Recent Development
Table 72. Solvay Company Detail
Table 73. Solvay Business Overview
Table 74. Solvay Follitropin Product
Table 75. Solvay Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 76. Solvay Recent Development
Table 77. Controlled Therapeutics Company Detail
Table 78. Controlled Therapeutics Business Overview
Table 79. Controlled Therapeutics Follitropin Product
Table 80. Controlled Therapeutics Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 81. Controlled Therapeutics Recent Development
Table 82. Vetter Pharma-Fertigung GmbH&Co. KG Company Detail
Table 83. Vetter Pharma-Fertigung GmbH&Co. KG Business Overview
Table 84. Vetter Pharma-Fertigung GmbH&Co. KG Follitropin Product
Table 85. Vetter Pharma-Fertigung GmbH&Co. KG Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 86. Vetter Pharma-Fertigung GmbH&Co. KG Recent Development
Table 87. MSD Company Detail
Table 88. MSD Business Overview
Table 89. MSD Follitropin Product
Table 90. MSD Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 91. MSD Recent Development
Table 92. IBSA Company Detail
Table 93. IBSA Business Overview
Table 94. IBSA Follitropin Product
Table 95. IBSA Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 96. IBSA Recent Development
Table 97. Livzon Company Detail
Table 98. Livzon Business Overview
Table 99. Livzon Follitropin Product
Table 100. Livzon Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 101. Livzon Recent Development
Table 102. Techwell Company Detail
Table 103. Techwell Business Overview
Table 104. Techwell Follitropin Product
Table 105. Techwell Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 106. Techwell Recent Development
Table 107. GenSci Company Detail
Table 108. GenSci Business Overview
Table 109. GenSci Follitropin Product
Table 110. GenSci Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 111. GenSci Recent Development
Table 112. Teva Company Detail
Table 113. Teva Business Overview
Table 114. Teva Follitropin Product
Table 115. Teva Revenue in Follitropin Business (2019-2024) & (US$ Million)
Table 116. Teva Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Follitropin Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Follitropin Market Share by Type: 2023 VS 2030
Figure 3. Urine-Derived Follicle Stimulating Hormone Features
Figure 4. Follitropin-α Features
Figure 5. Follitropin-β Features
Figure 6. Global Follitropin Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Follitropin Market Share by Application: 2023 VS 2030
Figure 8. Infertility Treatment Case Studies
Figure 9. Assisted Reproductive Technology Case Studies
Figure 10. Follitropin Report Years Considered
Figure 11. Global Follitropin Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Follitropin Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Follitropin Market Share by Region: 2023 VS 2030
Figure 14. Global Follitropin Market Share by Players in 2023
Figure 15. Global Top Follitropin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follitropin as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Follitropin Revenue in 2023
Figure 17. North America Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Follitropin Market Share by Country (2019-2030)
Figure 19. United States Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Follitropin Market Share by Country (2019-2030)
Figure 23. Germany Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Follitropin Market Share by Region (2019-2030)
Figure 31. China Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Follitropin Market Share by Country (2019-2030)
Figure 39. Mexico Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Follitropin Market Share by Country (2019-2030)
Figure 43. Turkey Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Follitropin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Gedeon Richter Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 46. Organon Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 47. Ferring Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 48. Emd Serono (Merck) Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 49. Johnson & Johnson Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 50. Solvay Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 51. Controlled Therapeutics Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 52. Vetter Pharma-Fertigung GmbH&Co. KG Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 53. MSD Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 54. IBSA Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 55. Livzon Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 56. Techwell Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 57. GenSci Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 58. Teva Revenue Growth Rate in Follitropin Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
